Non-alcoholic fatty liver disease (NAFLD) affects approximately 1 in 4 people worldwide and
is a major burden to health care systems. A major concern in NAFLD research is lack of …

As innovations in global agricultural production and food trading systems lead to major
dietary shifts, high morbidity rates from non-alcoholic fatty liver disease (NAFLD) …

Melatonin, an indole produced by pineal and extrapineal tissues, but also taken with a
vegetarian diet, has strong anti-oxidant, anti-inflammatory and anti-obesogenic potentials …

The study aimed to investigate the different effects of high-fat (HF) diets rich in different oils
on lipid metabolism, oxidative stress, and gut mirobiota. C57BL/6 mice were divided into 4 …

Moderate wine consumption is often associated with preventing obesity, yet concerns arise
due to the health risks linked to its constituent antioxidant, SO 2. Recent focus has turned to …

Acetaminophen (APAP)-induced acute hepatotoxicity is the leading cause of drug-induced
acute liver failure. The aim of this study was to evaluate the effects of 4-hydroxy-2, 2, 6, 6 …

The function of the central nervous system to regulate food intake can be disrupted by
sustained metabolic challenges such as high-fat diet (HFD), which may contribute to various …

Non-alcoholic fatty liver diseases (NAFLD) including the severe form with steatohepatitis
(NASH) are highly prevalent ailments to which no approved pharmacological treatment …

Introduction: Metabolic-associated fatty liver disease (MAFLD) is a common chronic
metabolic disease that seriously threatens human health. The pharmacological activity of …

Saroglitazar (SARO), a dual peroxisome proliferator activated receptor (PPAR)-α/γ agonist,
has been used to treat metabolic diseases such as insulin resistance and diabetic …